If You Invested $10K In Omega Healthcare Stock 10 Years Ago, How Much Would You Have Now?

Omega Healthcare Investors OHI is a real estate investment trust providing financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities located in the U.S. and the U.K.

It is set to report its Q1 2025 earnings on May 1. Wall Street analysts expect the company to post EPS of $0.75, up from $0.68 in the year-ago period. According to Benzinga Pro, quarterly revenue is expected to reach $276.66 million, up from $243.30 million a year earlier.

Don't Miss:

• ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.26/share with a $1000 minimum.
• Jeff Bezos-Backed Arrived Homes Hits A Big Sale On Charlotte Property – Investors Earning A 34.7% Return

If You Bought Omega Healthcare Stock 10 Years Ago

The company's stock traded at approximately $40.41 per share 10 years ago. If you had invested $10,000, you could have bought roughly 247 shares. Currently, shares trade at $38, meaning your investment's value could have declined to $9,404 from stock price depreciation. However, Omega Healthcare also paid dividends during these 10 years. 

Omega Healthcare's dividend yield is currently 7.05%. Over the last 10 years, it has paid about $24.11 in dividends per share, which means you could have made $5,966 from dividends alone. 

Summing up $9,404 and $5,966, we end up with the final value of your investment, which is $15,370. This is how much you could have made if you had invested $10,000 in Omega Healthcare stock 10 years ago. This means a total return of 53.7%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 235%.

Trending: Many are using retirement income calculators to check if they’re on pace — here’s a breakdown on what’s behind this formula.

What Could The Next 10 Years Bring? 

Omega Healthcare has a consensus rating of "Buy" and a price target of $36.11 based on the ratings of 21 analysts. The price target implies a nearly 5% potential downside from the current stock price.

On Feb. 5, the company announced its Q4 2024 earnings, posting FFO of $0.74, compared to the consensus estimate of $0.73, and revenues of $279.318 million, compared to the consensus of $275.668 million, as reported by Benzinga.

"The backdrop continues to be favorable. Operating metrics remain strong, with both occupancy and coverage modestly improving in the quarter. The pipeline remains very active, and we have a cost of capital that should allow us to continue to accretively invest," CEO Taylor Pickett said.

See Also: Dogecoin millionaires are increasing – investors with $1M+ in DOGE revealed!

The company provided its full-year 2025 guidance, expecting adjusted FFO to be between $2.90 and $2.98 per diluted share.

Given the expected downside potential, growth-focused investors may not find Omega Healthcare stock attractive. Conversely, the stock can be a good option for income-focused investors, who can benefit from the company's solid dividend yield of 7.05%.

Check out this article by Benzinga for three more stocks offering high dividend yields. 

Read Next:

• If You're Age 35, 50, or 60: Here’s How Much You Should Have Saved Vs. Invested By Now
• Inspired by Uber and Airbnb – Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets – with $1,000 you can invest at just $0.26/share!